Literature DB >> 11371656

Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up.

A Mahr1, T Girard, R Agher, L Guillevin.   

Abstract

OBJECTIVES: This prospective study attempted to determine factors predictive of survival in systemic Wegener's granulomatosis (WG) based on 49 patients. Patients and methods. All patients had previously untreated systemic WG. Treatment was with oral or pulse cyclophosphamide plus corticosteroids. Univariate and multivariate analyses of survival were performed using 13 parameters evaluated at diagnosis.
RESULTS: The mortality rate was 37% during a mean follow-up period of 1.9 yr. Among the 13 parameters evaluated, univariate analysis selected the following factors as predictors of a poor outcome: serum creatinine > or =18.1 mg/dl, age > or =57 yr, and erythrocyte sedimentation rate (ESR) > or =90 mm/1st h. The absence of ear, nose and throat (ENT) involvement also tended to predict a greater risk of mortality. Glomerulonephritis, when present and regardless of creatininaemia, and pulmonary involvement had no significant effect. Multivariate analysis retained serum creatinine > or =18.1 mg/dl and age > or =57 yr as significant predictors of poor prognosis.
CONCLUSIONS: Our results suggest that impaired renal function and older age are independent factors predicting poor outcome in WG. ESR proved to be a good marker of disease severity. Conversely, univariate analysis indicated that patients with ENT involvement tended to have a better outcome, suggesting a more benign evolution of granulomatous disease compared with more aggressive vasculitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371656     DOI: 10.1093/rheumatology/40.5.492

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.

Authors:  Zeynep Ozbalkan; Sedat Kiraz; M Akif Ozturk; A Ihsan Ertenli; Sule Apras; Meral Calguneri
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

Review 2.  Extensive intestinal ischaemic necrosis in Wegener's granulomatosis.

Authors:  F M Shaikh; C B Sabu; T H Peirce; S A Naqvi
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 3.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Bernhard Hellmich; Oliver Flossmann; Wolfgang L Gross; Paul Bacon; Jan Willem Cohen-Tervaert; Loic Guillevin; David Jayne; Alfred Mahr; Peter A Merkel; Heiner Raspe; David G I Scott; James Witter; Hasan Yazici; Raashid A Luqmani
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity.

Authors:  Antoine G Sreih; Ranadeep Mandhadi; Fadi Aldaghlawi; Asad Khan; Vajiha Irshad; Katherine Finn; Joel A Block
Journal:  Clin Rheumatol       Date:  2014-04-22       Impact factor: 2.980

5.  Epidemiology and Outcomes of Granulomatosis With Polyangiitis in Pediatric and Working-Age Adult Populations In the United States: Analysis of a Large National Claims Database.

Authors:  Sirada Panupattanapong; Dustin L Stwalley; Andrew J White; Margaret A Olsen; Anthony R French; Mary E Hartman
Journal:  Arthritis Rheumatol       Date:  2018-12       Impact factor: 10.995

6.  Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.

Authors:  Nobuyuki Ono; Hiroaki Niiro; Akira Ueda; Takuya Sawabe; Hiroaki Nishizaka; Isao Furugo; Seiji Yoshizawa; Shigeru Yoshizawa; Hiroshi Tsukamoto; Chikako Kiyohara; Yoshifumi Tada; Takahiko Horiuchi
Journal:  Rheumatol Int       Date:  2014-08-17       Impact factor: 2.631

Review 7.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 8.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 9.  [Development of morbidity and mortality in ANCA-associated vasculitis].

Authors:  E Reinhold-Keller; F Moosig
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

10.  Wegener granuloma in the fourth ventricle.

Authors:  Ansgar Berlis; Franziska Petschner; Ingolf Carl Bötefür; Joachim Spreer
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.